MiNDERA Corporation

company

About

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$3.50M
Industries
Biotechnology,Health Care,Medical
Founded date
Dec 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.

It was founded in 2013 and is based in San Francisco, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$20.52M
MiNDERA Corporation has raised a total of $20.52M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 3, 2022 Debt Financing $3.50M Detail
May 12, 2021 Series A $12M 3 Mountain Group Capital
Rockmont Investments
Scientific Health Development Partners
Detail
Nov 16, 2018 Seed $2.92M Detail
Dec 1, 2016 Seed 3 Detail
Oct 13, 2015 Seed $1M 2 Detail

Investors

Number of Lead Investors
Number of Investors
3
8
MiNDERA Corporation is funded by 8 investors. Mountain Group Capital and Rockmont Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Mountain Group Capital Yes Series A
Rockmont Investments Yes Series A
Scientific Health Development Partners Yes Series A
MIT Alumni Angels of Northern California Seed
Primer Capital Seed
Andrew Offer Seed
MedTech Innovator Grant
Philippe Nore Grant

Employee Profiles

Number of Employee Profiles
3
MiNDERA Corporation has 3 current employee profiles, including Executive Martyn Gross
Executive
Executive
Executive